Johnson Investment Counsel Inc Collegium Pharmaceutical, Inc Transaction History

Johnson Investment Counsel Inc

$10.1 Billion
Q3 2024

A detailed history of Johnson Investment Counsel Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Johnson Investment Counsel Inc holds 6,436 shares of COLL stock, worth $192,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,436

Previous 6,436 -0.0%

Holding current value

$192,822

Previous $207,000 19.81%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$31.36 - $39.99 $27,784 - $35,431	-886 Reduced 12.1%	6,436 $207,000
Q1 2024 May 09, 2024	SELL	$31.23 - $40.91 $31,698 - $41,523	-1,015 Reduced 12.17%	7,322 $284,000
Q4 2023 Feb 07, 2024	BUY	$21.16 - $30.8 $176,410 - $256,779	8,337 New	8,337 $256,000
Q2 2023 Aug 10, 2023	SELL	$21.06 - $24.0 $14,447 - $16,464	-686 Reduced 6.73%	9,512 $204,000
Q1 2023 May 15, 2023	SELL	$23.0 - $29.88 $2.23 Million - $2.9 Million	-96,988 Reduced 90.49%	10,198 $244,000
Q4 2022 Feb 14, 2023	SELL	$16.14 - $23.55 $322,057 - $469,916	-19,954 Reduced 15.69%	107,186 $2.49 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $23,298 - $30,290	1,507 Added 1.2%	127,140 $2.04 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $24,344 - $35,746	-1,712 Reduced 1.34%	125,633 $2.23 Million
Q1 2022 May 11, 2022	BUY	$17.2 - $22.5 $26,144 - $34,200	1,520 Added 1.21%	127,345 $2.59 Million
Q4 2021 Feb 15, 2022	BUY	$17.5 - $21.35 $21,752 - $26,538	1,243 Added 1.0%	125,825 $2.35 Million
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $600,180 - $858,512	33,813 Added 37.25%	124,582 $2.46 Million
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $3,739 - $4,348	-172 Reduced 0.19%	90,769 $2.15 Million
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $107,434 - $145,664	5,581 Added 6.54%	90,941 $2.16 Million
Q4 2020 Feb 12, 2021	BUY	$17.83 - $22.29 $24,070 - $30,091	1,350 Added 1.61%	85,360 $1.71 Million
Q3 2020 Nov 16, 2020	BUY	$15.78 - $20.82 $423,030 - $558,142	26,808 Added 46.87%	84,010 $1.75 Million
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $886,058 - $1.34 Million	57,202 New	57,202 $1 Million

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.

Account

Johnson Investment Counsel Inc Collegium Pharmaceutical, Inc Transaction History